Brain ResearchPub Date : 2026-08-15Epub Date: 2026-04-25DOI: 10.1016/j.brainres.2026.150345
Tao Tao, Chun-Lei Li, Wan-Chao Yang, Xian-Zhang Zeng, Chun-Yu Song, Zi-Yong Yue, Hong Dong, Hua Qian
{"title":"Expression of concern: \"Protective effects of propofol against whole cerebral ischemia/reperfusion injury in rats through the inhibition of the apoptosis-inducing factor pathway\" [Brain Res. 1644 (2016) 9-14].","authors":"Tao Tao, Chun-Lei Li, Wan-Chao Yang, Xian-Zhang Zeng, Chun-Yu Song, Zi-Yong Yue, Hong Dong, Hua Qian","doi":"10.1016/j.brainres.2026.150345","DOIUrl":"https://doi.org/10.1016/j.brainres.2026.150345","url":null,"abstract":"","PeriodicalId":9083,"journal":{"name":"Brain Research","volume":"1885 ","pages":"150345"},"PeriodicalIF":2.6,"publicationDate":"2026-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147863585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Brain ResearchPub Date : 2026-05-07DOI: 10.1016/j.brainres.2026.150375
I Hernández-Bustamante, P Soberanes-Chávez, K Simón-Arceo, V M Magdaleno-Madrigal, E Espitia-Bautista, P de Gortari
{"title":"Type-1 thyrotropin-releasing hormone receptor in the nucleus accumbens participates in the anorectic effect of the stimulation of central nucleus of the amygdala.","authors":"I Hernández-Bustamante, P Soberanes-Chávez, K Simón-Arceo, V M Magdaleno-Madrigal, E Espitia-Bautista, P de Gortari","doi":"10.1016/j.brainres.2026.150375","DOIUrl":"https://doi.org/10.1016/j.brainres.2026.150375","url":null,"abstract":"<p><p>Thyrotropin-releasing hormone (TRH) is a hypothalamic neuropeptide that directs the thyroid axis function. Beyond this classical role, TRH is also synthesized in extrahypothalamic brain regions, where it is implicated with anorectic, anxiolytic and antiepileptic effects. Its anorectic role is supported by the reduced food intake of fasted rats when refed, after TRH is injected into their nucleus accumbens (NAc). The central nucleus of the amygdala (CeA) contains TRHergic cells, and its electrical stimulation (ES) induces a hypophagic effect on rats and transsynaptic changes in TRH content in the NAc and other brain regions. Since the G-protein-coupled type-1-TRH receptor is expressed in the NAc, we evaluated its participation in ES-amygdala-induced feeding regulation by using the electrical amygdaloid kindling model and by injecting antisense oligonucleotides (ASO) against type-1 TRH receptor (TRH-R1) in the NAc of rats. Male Wistar rats with an implanted electrode in CeA received daily ES (1 s, 60 Hz, 1 ms pulses) for seven days; then, fasted 48-h and on day 10, receiving a last ES, and refed for 2 h. Amygdala TRH mRNA expression was analyzed by in situ hybridization, while accumbal pro-TRH content by Western blot and immunohistochemistry. Amygdalar stimulation increased TRH mRNA in CeA, cortical amygdala and medial amygdalar nucleus; pro-TRH content increased in shell of NAc. Importantly, intra-NAc shell administration of ASO targeting TRH-R1, reversed the reduced food intake induced by CeA stimulation. These findings support the functional role of TRH-R1 in the NAc for the CeA electrical stimulation-induced hypophagia observed in re-fed fasted rats.</p>","PeriodicalId":9083,"journal":{"name":"Brain Research","volume":" ","pages":"150375"},"PeriodicalIF":2.6,"publicationDate":"2026-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147863550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Brain ResearchPub Date : 2026-05-04DOI: 10.1016/j.brainres.2026.150367
Zhu Yan, Liu Puyi, Zhang Peng, Ye Haimin, Shi Xuehui, Liu Weiai, Kang Zhen
{"title":"Electroacupuncture at \"Siguan\" acupoints alleviates post-stroke depression by inhibiting ER stress-induced apoptosis in the prefrontal cortex.","authors":"Zhu Yan, Liu Puyi, Zhang Peng, Ye Haimin, Shi Xuehui, Liu Weiai, Kang Zhen","doi":"10.1016/j.brainres.2026.150367","DOIUrl":"https://doi.org/10.1016/j.brainres.2026.150367","url":null,"abstract":"<p><p>This study investigated the complex mechanisms underlying post-stroke depression (PSD) and the challenges associated with its clinical prevention and treatment. Specifically, it examined the effects of electroacupuncture at the \"Siguan\" acupoints on PSD and the relationship with the PERK-ATF4-CHOP endoplasmic reticulum stress (ERS) pathway. A rat model of PSD was established by combining middle cerebral artery occlusion (MCAO) with solitary rearing and chronic unpredictable mild stress (CUMS). Successfully modeled rats were randomly assigned to four groups: the model group, the electroacupuncture group, the drug group, and the sham operation group. The electroacupuncture group received 21 days of electroacupuncture at the \"Siguan\" acupoints (bilateral Hegu LI4 and Taichong LR3). Behavioral changes were assessed using a blinded method. Histopathological and molecular biological methods were then employed to comprehensively examine neuronal damage, apoptosis, and the expression of key proteins in the ERS pathway in the prefrontal cortex.The results showed that, compared with the model group, both electroacupuncture and medication significantly improved depressive‑like behavior, alleviated neuronal injury in the prefrontal cortex, and reduced apoptosis. At the molecular level, these effects were significantly associated with inhibition of the PERK-ATF4-CHOP ERS pathway, as evidenced by decreased levels of GRP78, p-PERK, CHOP, and downstream pro‑apoptotic proteins (Bax and cleaved caspase‑3). Notably, electroacupuncture demonstrated particular efficacy in promoting weight gain and modulating pathways such as p-PERK. These findings suggest that electroacupuncture at the \"Siguan\" acupoints may alleviate depressive‑like behavior in PSD rats by inhibiting the PERK-ATF4-CHOP pathway in the prefrontal cortex, thereby reducing endoplasmic reticulum stress‑induced neuronal apoptosis. This provides a novel potential molecular mechanism for electroacupuncture treatment of PSD.</p>","PeriodicalId":9083,"journal":{"name":"Brain Research","volume":" ","pages":"150367"},"PeriodicalIF":2.6,"publicationDate":"2026-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147833626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Brain ResearchPub Date : 2026-04-01Epub Date: 2026-02-07DOI: 10.1016/j.brainres.2026.150201
Yi Liu , Junhua Ding , Songjian Wang , Nuonan Kou , Shuo Wang
{"title":"Increased hemispheric functional connectivity compensates speech perception in older adults with hearing loss","authors":"Yi Liu , Junhua Ding , Songjian Wang , Nuonan Kou , Shuo Wang","doi":"10.1016/j.brainres.2026.150201","DOIUrl":"10.1016/j.brainres.2026.150201","url":null,"abstract":"<div><div>Age-related hearing loss (ARHL) is associated with widespread cortical reorganization, yet the adaptive mechanisms of functional connectivity across disease stages and brain states remain unclear. Using functional near-infrared spectroscopy (fNIRS), we examined both resting-state and speech perception-evoked functional connectivity (FC) in older adults with normal hearing, mild hearing loss, or moderate-to-severe hearing loss. FC alterations were found to be both state-dependent (i.e., varying with the cognitive state) and stage-dependent (i.e., depending on the severity of hearing loss). At rest, only the most impaired group showed localized increases in right-hemispheric FC. During speech perception, the mildly impaired group exhibited widespread FC enhancements across cross-hemispheric networks. These task-evoked enhancements were absent in the severely impaired group, suggesting a breakdown in adaptive recruitment. Subnetwork-level analyses further revealed spatially specific alterations in right-lateralized frontoparietal and frontotemporal circuits, as well as interhemispheric pathways linking left-hemisphere language hubs with right-hemisphere regions supporting attention, executive function, and top-down linguistic prediction. Collectively, our findings delineate a nonlinear trajectory of neural adaptation in ARHL, highlight a temporally bounded window of plasticity in early stages, and underscore the essential role of cross-hemispheric reorganization in sustaining speech processing under cognitive load.</div></div>","PeriodicalId":9083,"journal":{"name":"Brain Research","volume":"1876 ","pages":"Article 150201"},"PeriodicalIF":2.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146149000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Brain ResearchPub Date : 2026-04-01Epub Date: 2026-02-01DOI: 10.1016/j.brainres.2026.150189
Shiyuan Xue , Die Hu , Liping Li , Yuerong Sun , Xinyi Wei , Yan Xiao , Qiling Jiang , Chao Qi , Haitao Fu
{"title":"Identification of repopulated microglia-associated genes in microglia depleted/repopulated mice after spinal cord injury","authors":"Shiyuan Xue , Die Hu , Liping Li , Yuerong Sun , Xinyi Wei , Yan Xiao , Qiling Jiang , Chao Qi , Haitao Fu","doi":"10.1016/j.brainres.2026.150189","DOIUrl":"10.1016/j.brainres.2026.150189","url":null,"abstract":"<div><div>This study aimed to investigate the effects of repopulated microglia on neural repair and functional recovery and identify repopulated microglia-associated repair-promoting genes after spinal cord injury (SCI) in mice following depletion of microglia via the colony-stimulating factor 1 receptor (CSF1R) inhibitor PLX3397. Mice were divided into control, sustained microglial depletion, and microglial depletion/repopulation groups according to being treated standard or PLX3397 diet. Mice in all groups were subjected to a complete spinal cord crush injury. Comprehensive assessments were performed using behavioral scoring, immunofluorescence staining 21 days post-injury, and RNA sequencing 21 days post-injury. Results demonstrated that PLX3397 effectively eliminated approximately 95 % of microglia in the mouse spinal cord. Upon drug withdrawal, microglia rapidly repopulated and exhibited a pro-regenerative phenotype. Repopulated microglia significantly promoted post-injury motor functional recovery, increased neuronal survival, and reduced glial scar formation. Transcriptomic analysis identified genes associated with repopulated microglia, which were enriched in immune response, complement activation, phagocytosis, and cytokine signaling pathways. Protein-protein interaction (PPI) network analysis of these associated genes further pinpointed key genes, including<!--> <em>Il1b</em>,<!--> <em>Ccr2</em>, and <em>Il15</em>. This study reveals that repopulated microglia may exert neuroprotective effects by modulating the immune microenvironment. The 336 repopulated microglia-associated genes identified in this study, and the identified key genes that are preferentially upregulated in repopulated microglia may represent novel therapeutic targets for SCI.</div></div>","PeriodicalId":9083,"journal":{"name":"Brain Research","volume":"1876 ","pages":"Article 150189"},"PeriodicalIF":2.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146112387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Brain ResearchPub Date : 2026-04-01Epub Date: 2026-02-03DOI: 10.1016/j.brainres.2026.150187
Henrique José Cavalcanti Bezerra Gouveia , Osmar Henrique dos Santos-Júnior , Johannes Frasnelli , Alexandre Fisette , Joaci Pereira dos Santos Júnior , Marcos Antônio da Silva Araújo , Eulália Rebeca da Silva-Araújo , Ana Elisa Toscano , Raul Manhães de Castro
{"title":"Ghrelin-based interventions in preclinical models of Parkinson’s disease: a systematic review","authors":"Henrique José Cavalcanti Bezerra Gouveia , Osmar Henrique dos Santos-Júnior , Johannes Frasnelli , Alexandre Fisette , Joaci Pereira dos Santos Júnior , Marcos Antônio da Silva Araújo , Eulália Rebeca da Silva-Araújo , Ana Elisa Toscano , Raul Manhães de Castro","doi":"10.1016/j.brainres.2026.150187","DOIUrl":"10.1016/j.brainres.2026.150187","url":null,"abstract":"<div><div>Ghrelin plays a crucial role in metabolism and gastrointestinal function. In the central nervous system, ghrelin modulates both hedonic and homeostatic control of eating behavior. Ghrelin promotes neuron survival by reducing apoptosis, inflammation, and oxidative stress, making it a potential therapeutic agent for neurodegenerative diseases. Parkinson’s Disease (PD) is a neurodegenerative disease characterized by motor and non-motor symptoms. The motor impairments result primarily from the progressive degeneration of dopaminergic neurons in the substantia nigra pars compacta. Individuals with PD exhibit reduced levels of fasting and postprandial plasma ghrelin, and its receptors (GHSR) are expressed in the substantia nigra. Thus, this review aimed to evaluate the effects of ghrelin or GHSR agonists administration in experimental models of PD. A systematic search was conducted across PubMed, Scopus, Web of Science, and Embase. The 12 included studies involved PD models induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), 6-hydroxydopamine (6-OHDA), as well as A53T transgenic mice. Interventions were performed with acylated and/or des-acylated ghrelin, in addition to the GHSR agonist HM01. Intervention with ghrelin was able to reduce dopaminergic neurodegeneration and improve motor function, while also positively impacting metabolic and gastrointestinal functions, expanding its relevance to non-motor consequences of PD. Considering that most results were obtained using acute toxin-induced models and only male animals, further studies using progressive PD models and evaluating sex differences are needed. Thus, although preclinical evidence supports ghrelin or GHSR agonists as promising agents for treatment, future studies will be essential to inform clinical translation and optimize therapeutic strategies for individuals with PD.</div></div>","PeriodicalId":9083,"journal":{"name":"Brain Research","volume":"1876 ","pages":"Article 150187"},"PeriodicalIF":2.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146123847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Brain ResearchPub Date : 2026-04-01Epub Date: 2026-02-05DOI: 10.1016/j.brainres.2026.150191
Çağdaş Güdücü , Güliz Akın Öztürk , Zehra Ülgen
{"title":"Alpha suppression during non-painful tactile stimulation","authors":"Çağdaş Güdücü , Güliz Akın Öztürk , Zehra Ülgen","doi":"10.1016/j.brainres.2026.150191","DOIUrl":"10.1016/j.brainres.2026.150191","url":null,"abstract":"<div><div>Alpha-band power is considered as a marker of sensory processing–related cortical states, including sensory suppression and the temporal organization of sensory input. This study aimed to investigate whether alpha-band power of electrophysiological brain responses is modulated by different interstimulus intervals during repetitive, non-painful tactile stimulation. Non-painful tactile stimuli were delivered to the index finger of the right hand with different interstimulus intervals (ISI) of 2 s (s), 4 s, and 8 s via a pneumatic stimulator. A separate session was conducted for each ISI in a pseudorandomized order. The electroencephalogram was recorded in all sessions with 24 volunteers. The results of the analysis showed that the alpha activity was lowest at ISI<sub>4</sub> and highest at ISI<sub>8</sub>. This pattern was consistently observed in both the central and parietal regions. In the ISI<sub>2</sub> session, although no notable variation among the frontal, central, and parietal areas was observed, the most pronounced activity was observed in the frontal region in the ISI<sub>4</sub> session. The highest level of alpha activity was observed in the central area during the ISI<sub>8</sub> session. Variations in interstimulus intervals affect inhibitory control and sensory processing in the brain. The frontal cortex appears to manage attention and cognitive control more efficiently at intermediate intervals (ISI<sub>4</sub>), whereas the central region shows greater involvement in processing tactile inputs at longer intervals (ISI<sub>8</sub>).</div></div>","PeriodicalId":9083,"journal":{"name":"Brain Research","volume":"1876 ","pages":"Article 150191"},"PeriodicalIF":2.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146137031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Role of the dentate gyrus of hippocampus on acute pain modulation: Investigating of dopaminergic-opioidergic interactions in pain-related behaviors in the tail-flick test","authors":"Sahar Sadeghzadeh Sotoudeh , Shima Abtin , Roghayeh Mozafari , Abbas Haghparast","doi":"10.1016/j.brainres.2026.150155","DOIUrl":"10.1016/j.brainres.2026.150155","url":null,"abstract":"<div><div>Previous studies have shown that injections of opioid and dopamine agonists alone into the dentate gyrus (DG) increase the threshold for acute pain responses. Therefore, this study aimed to investigate whether the opioid and D1-like dopamine receptor (D1R) interact to modulate acute pain in DG. One hundred and forty-seven adult male Wistar rats were cannulated unilaterally in the DG. Separate groups of animals received different doses of SCH23390 (6, 12, and 24 mmol/0.5 μL), a D1R antagonist, before injection of an effective dose of morphine (25 mmol/0.5 μL). In another experiment, animals received different naloxone (5, 15, and 45 mmol/0.5 μL) dose, an opioid receptor antagonist, before administering the effective dose of SKF38393 (6 mmol/0.5 μL). Acute pain threshold was assessed using the tail-flick test. Behavioral data analysis indicated that blockade of D1R in the DG significantly attenuated morphine-induced antinociception (P < 0.001). Furthermore, the antinociceptive effects of SKF38393 were significantly reduced by blocking opioid receptors in the DG (P < 0.01). Interestingly, the effect of SCH23390 in reducing the antinociceptive effects of morphine (η2 = 0.65) was numerically higher than the effect of naloxone in reducing the antinociceptive effects of SKF38393 (η2 = 0.46). The results suggest a strong interaction between opioidergic and dopaminergic systems in the DG in modulating acute pain. These findings can be used to reveal the precise mechanisms of pain modulation in brain circuits and to develop new strategies in pain management with greater efficacy and fewer side effects.</div></div>","PeriodicalId":9083,"journal":{"name":"Brain Research","volume":"1875 ","pages":"Article 150155"},"PeriodicalIF":2.6,"publicationDate":"2026-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145942368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Evaluation of neurobiochemical and behavioral responses to carvone nanoemulsion: A neuroprotective approach for Alzheimer’s disease-associated dementia in a rat model","authors":"Sahand Kabiri , Pariya Gholizadeh Dangheralou , Farnaz Khazaeifard , Samir Rostami Mehr , Seyedeh Mohadeseh Mansouri , Nahal Rahimi Rad , Saeid Abbasi-Maleki","doi":"10.1016/j.brainres.2026.150143","DOIUrl":"10.1016/j.brainres.2026.150143","url":null,"abstract":"<div><h3>Background</h3><div>Antioxidant supplements have emerged as promising strategies to mitigate the impact of Alzheimer’s disease (AD) and associated dementia. We explored the neuroprotective potential of Carvone nanoemulsion (CANO) using a rat model of AD-associated dementia.</div></div><div><h3>Method</h3><div>Our experimental groups comprised non-AD control rats (CON), untreated AD rats (AD), and AD rats treated with CANO at two different dosages: 40 mg/kg (CANO40) and 80 mg/kg (CANO80). We assessed various behavioral parameters, malondialdehyde (MDA) and brain-derived neurotrophic factor (BDNF) levels,<!--> <!-->ferric-reducing ability of plasma (FRAP).</div></div><div><h3>Results</h3><div>AD induction caused a significant reduction in step-through latency (P < 0.001), center time (P < 0.001), the number of visits (P < 0.001), and total distance traveled (P < 0.001), time spent in open arms (P < 0.001), and both FRAP (P < 0.001) and BDNF levels (P < 0.001) in comparison to the CON group, while elevating escape latency, time in target zone and platform location latency, and MDA levels (P < 0.001). Treatment with CANO, particularly at the CANO80 dosage, significantly improved these parameters compared to the AD group, resulting in decreased time in the target zone (P < 0.001), escape latency (P < 0.001), and platform location latency (P < 0.001) and higher FRAP (P < 0.05) and BDNF levels (P < 0.05), along with decreased MDA levels (P < 0.05).</div></div><div><h3>Conclusion</h3><div>CANO, especially at the 80 mg/kg dosage, shows promise in alleviating symptoms associated with AD-associated dementia. However, further research is warranted to validate and expand upon these findings.</div></div>","PeriodicalId":9083,"journal":{"name":"Brain Research","volume":"1875 ","pages":"Article 150143"},"PeriodicalIF":2.6,"publicationDate":"2026-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145899448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}